Item 3.01 Notice of Delisting of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On November 21, 2012, Senesco Technologies, Inc. (the "Company") announced that, following the delisting of the Company's common stock from the NYSE MKT, the Company's common stock will be quoted on the OTC.QB under the ticker symbol SNTI beginning on Wednesday, November 21, 2012,. The Company plans to continue to be a fully reporting issuer compliant with applicable federal and state regulations.

Item 8.01 Other Information.

Additionally, the Company reported that the board of directors and management of the Company had decided not to engage in a highly-dilutive financing in order to maintain the Company's listing on the NYSE MKT. The Company plans to use any proceeds received from a future financing to continue to progress the ongoing SNS01-T clinical trial.

Senesco plans to release a corporate update on Monday, November 26th, 2012, by way of a press release, to describe progress on various aspects of the business.

The press release announcing the quotation of the Company's common stock on the OTC is attached as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description

99.1 Press Release of Senesco Technologies, Inc. dated November 21, 2012.